STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
35 hedge funds and large institutions have $104M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
-10
Holders Change %
-22.22%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
11
Closed
12
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$171K
Top Buyers
| 1 |
CC
Commodore Capital
New York
|
$16.7M |
| 2 |
SC
Samlyn Capital
New York
|
$7.96M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$432K |
| 4 |
State Street
Boston,
Massachusetts
|
$161K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$2.95M |
